Ad is loading...
TRIEX
Price
$23.49
Change
+$0.08 (+0.34%)
Updated
Nov 22 closing price
VTSNX
Price
$130.78
Change
+$0.28 (+0.21%)
Updated
Nov 22 closing price
Ad is loading...

TRIEX vs VTSNX

Header iconTRIEX vs VTSNX Comparison
Open Charts TRIEX vs VTSNXBanner chart's image
Nuveen International Eq Idx Retire
Price$23.49
Change+$0.08 (+0.34%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index I
Price$130.78
Change+$0.28 (+0.21%)
VolumeN/A
CapitalizationN/A
TRIEX vs VTSNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
TRIEX vs. VTSNX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TRIEX is a Buy and VTSNX is a Buy.

FUNDAMENTALS
Fundamentals
VTSNX has more cash in the bank: 442B vs. TRIEX (26.9B). VTSNX pays higher dividends than TRIEX: VTSNX (3.29) vs TRIEX (2.67). TRIEX was incepted earlier than VTSNX: TRIEX (22 years) vs VTSNX (14 years). TRIEX is a more actively managed with annual turnover of: 5.00 vs. VTSNX (4.00). TRIEX has a lower initial minimum investment than VTSNX: TRIEX (0) vs VTSNX (5000000). TRIEX (10.66) and VTSNX (10.30) have marching annual gain over last year. TRIEX return over 5 years is better than : 27.57 vs. VTSNX (17.41).
TRIEXVTSNXTRIEX / VTSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years14 years-
Gain YTD4.3235.25382%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets26.9B442B6%
Annual Yield % from dividends2.673.2981%
Returns for 1 year10.6610.30104%
Returns for 3 years3.74-3.36-111%
Returns for 5 years27.5717.41158%
Returns for 10 years40.5629.64137%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PTPI0.260.01
+3.92%
Petros Pharmaceuticals
TR32.940.53
+1.64%
Tootsie Roll Industries
CDNA22.580.21
+0.94%
CareDx
ATR169.881.15
+0.68%
AptarGroup
IPSC1.24-0.02
-1.59%
Century Therapeutics